SOPHYSA
Megi Novi is an experienced professional currently serving as the Post Marketing Surveillance, Vigilance, and Complaints Manager at SOPHYSA since April 2022, where responsibilities include managing materiovigilance reports, customer complaints, and conducting statistical analysis to propose corrective actions. Prior roles within SOPHYSA involved clinical affairs and post-market vigilance, emphasizing client complaint management and trend reporting. Earlier experience includes an internship at IGBMC, focusing on DNA extractions and various laboratory tests. Megi Novi holds a Master's degree in Medical Device: Registration, Evaluation and Vigilance from Université Paris-Saclay, a Master's degree in Development of Drugs and other Health Products from the University of Montpellier, and a Bachelor's degree in Life Sciences from the University of Strasbourg, complemented by a high school diploma in Natural Sciences from Mehmet Akif College.
This person is not in any teams
SOPHYSA
Founded in 1976, SOPHYSA is a French company pioneer in the development of adjustable neurosurgical valves, the most advanced type of valves for the treatment of Hydrocephalus. Indeed, they offer the possibility to neurosurgeons to adjust the operating pressure non-invasively depending on patient's clinical needs. Two adjustable valves are produced by SOPHYSA: the Sophy® Mini valve, which was the first adjustable valve in the world, launched in 1985, and the Polaris® valve, the first MRI-stable adjustable valve. In addition to a complete range of neurosurgical implants, SOPHYSA offers a continuous intracranial pressure measurement system required for patients with a trauma brain injury, hydrocephalus, and hematoma. Pressio® ICP monitoring system is a user-friendly monitor with its range of catheters for intracranial pressure and temperature measurements.